Fundraising Fox

Propria

Madison, US · Founded 2018 · Delaware LLC

Propria develops a patented system for producing and analyzing human engineered heart tissue (hEHT), generating detailed datasets on the contractile function of human cardiac tissue. It serves academic groups, pharmaceutical companies, and biotech and gene therapy firms.

BiotechDeep TechMedical Devices

Founders & leadership

Propria was founded in 2018 by Stuart Campbell.

SCStuart Campbell
Stuart CampbellinFounder
SJStephanie Jacoby
Stephanie JacobyinNamed on SEC filing
BW
Bryan WackerNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$574K disclosed across 2 rounds · 2018–2019

▶$121KraisedDec 2019 · 3 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stuart CampbellDirector
  • Stephanie JacobyExecutive Officer, Director
Offering amount
$1M
Amount sold
$121K
First sale
Dec 2019
Incorporated
Limited Liability Company, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$453KraisedJun 2018 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephanie JacobyExecutive Officer
  • Bryan WackerExecutive Officer
  • Stuart Gaylon CampbellDirector
Offering amount
$1M
Amount sold
$453K
First sale
May 2018
Incorporated
Limited Liability Company, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap
MyoLab4 shared keywordsMyolab develops MyoSapiens, an embodied AI system designed to understand and learn from human full-body movements, behaviors, and interactions by combining embodied behavior data with environmental context and world knowledge.
Proprio3 shared keywordsProprio develops Paradigm, an implant-agnostic surgical platform that provides intraoperative guidance and structured surgical data without requiring 3D imaging or mobile CT. The system is built for hospitals and health systems to increase surgical capacity, standardize performance, and support clinical training through an AI foundation model trained on data from hundreds of surgeons.
Proscia3 shared keywordsProscia provides a digital pathology software platform that converts glass microscope slides into high-resolution digital images for viewing, management, and analysis by pathologists and research teams. The platform enables clinical laboratories and life sciences organizations to improve workflow efficiency, support remote collaboration, and integrate artificial intelligence tools for quantitative tissue analysis and biomarker detection.

Companies competing with Propria for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$259.6K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Propria do?
Propria develops a patented system for producing and analyzing human engineered heart tissue (hEHT), generating detailed datasets on the contractile function of human cardiac tissue. It serves academic groups, pharmaceutical companies, and biotech and gene therapy firms.
Who founded Propria?
Propria was founded by Stuart Campbell in 2018.
How much funding has Propria raised?
Propria has disclosed $574K raised across 2 rounds.
Where is Propria headquartered?
Propria is headquartered in Madison, US.